A

A macro–micro–macro radiogenomic framework identifies FIBCD1 as a key immune-modulating biomarker in breast cancer

Journal of Translational Medicine

Authors 0

  1. Author list not loaded yet.

Cited by 0 stored of 3

References 1

1 result